Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion

  • Home
  • /
  • Publication
  • /
  • Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion



Réference
Leukemia Research 35 (2011) e175-e176

Auteurs
Sondes Hadiji Mseddi ,Faten Kallel Olfa Kassar Moez Elloumi Department of Hematology, University of Sfax, HediChaker Hospital, Sfax, Tunisia Ines Jedidi Hematology Laboratory, Habib Bourguiba Hospital, Sfax, Tunisia

Date de publication
11/06/2011


Download Document